SecBot SecBot
6-K ·Filed Jul 22, 2026

AKZOY

AKZO NOBEL NV
MIXED
Impact 5/10
Horizonweeks Processed3mo ago SEC0001193125-26-311868
Notable filing: 6-K
Actionable Insight ◆ Mixed

Monitor Q3 2026 revenue trend for confirmation of organic growth trajectory and watch for Axalta merger milestones (shareholder vote Aug 5, 2026). The improved leverage and margin expansion support the credit profile, but the revenue decline and lower free cash flow warrant caution.

DirectionMixed
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$22.10
T+0 close · Jul 22, 2026 · via day close
Latest settled
−0.32%
T+60 · $22.03
Vs SPY
−3.84%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 22 $22.10entry
  2. T+1 · 4mo ago −3.67%α −2.43% · $21.29
  3. T+5 · 4mo ago +5.11%α +7.51% · $23.23
  4. T+20 · 3mo ago +6.74%α +3.85% · $23.59
  5. T+60 · 5w ago −0.32%α −3.84% · $22.03

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

AkzoNobel reported Q2 2026 revenue of €2,589M (-1% YoY) with operating income up 17% to €251M and adjusted EBITDA margin improving to 15.4%. Organic sales grew 2% on pricing, but revenue was impacted by divestments and FX. The company expects full-year adjusted EBITDA at or above €1.47B and maintains its Axalta merger timeline for late 2026/early 2027. The mixed results show profitability improvement against a backdrop of modest revenue decline.

Key Facts

  • Q2 2026 revenue €2,589M, down 1% YoY (H1 down 5% to €4,975M)
  • Operating income €251M, up 17% YoY (H1 €428M, up 5%)
  • Adjusted EBITDA €398M, up 1% YoY (H1 €743M, down 1%)
  • Adjusted EBITDA margin 15.4% vs 15.0% in Q2 2025
  • Net income attributable to shareholders €139M vs €124M
  • EPS from total operations €0.81 vs €0.73; adjusted EPS from continuing ops €1.07 vs €1.13
  • Free cash flow €108M vs €162M in H1 2025
  • Leverage ratio improved to 2.2x from 2.9x
  • Outlook: full-year adjusted EBITDA at or above €1.47B in constant currencies
  • Axalta all-stock merger expected to close late 2026/early 2027; special dividend of €2.5B conditional on completion

Financial Impact

Revenue declined 1% in Q2 and 5% in H1, but operating income grew 17% in Q2 and 5% in H1. Adjusted EBITDA margin expanded 40bps in Q2. Free cash flow declined 33% in H1.

revenueoperating incomeadjusted EBITDAepsfree cash flow

Risk Factors

  • Revenue decline from FX headwinds and divestments
  • Merger execution risk and regulatory approvals for Axalta deal
  • Raw material inflation and geopolitical instability (Middle East, Russia)
  • Project Ichthys litigation exposure (AUD 4.8B claim)

Market Snapshot

Exchange
OTC
Analyst Consensus
54% bullish (24 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001193125-26-311868
Document: d150329d6k.htm0001193125-26-311868
Document: 0001193125-26-311868-index-headers.html0001193125-26-311868
Document: 0001193125-26-311868-index.html0001193125-26-311868
Document: 0001193125-26-311868.txt0001193125-26-311868

US Market Status

Market Closed · Opens in 7h 32m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 22, 2026